Loading…

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) 2022-10, Vol.174, p.S1-S2
Main Authors:	Cho, B.C., Lin, J., Camidge, D.R., Velcheti, V., Solomon, B., Lu, S., Lee, K.H., Kim, S.W., Kao, S., Diadziuskzko, R., Beg, M., Nagasaka, M., Felip, E., Besse, B., Springfeld, C., Popat, S., Wolf, J., Trone, D., Stopatschinskaja, S., Drilon, A.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!